Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Wright

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Practical Radiation Oncology|March 19, 2022
Stricter Postoperative Oropharyngeal Cancer Radiation Therapy Normal Tissue Dose Constraints Are FeasibleWilliam Su, Christopher M Wright, Daniel Y Lee, et al.
Cancer Research|November 19, 2015
Fibulin-5 Blocks Microenvironmental ROS in Pancreatic CancerMiao Wang, Mary Topalovski, Jason E Toombs, et al.
Practical Radiation Oncology|July 6, 2024
Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell LymphomaJonathan A Baron, Christopher M Wright, Alexandra D Dreyfuss, et al.
Advances in Radiation Oncology|December 19, 2022
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee CollaborationJonathan A Baron, Christopher M Wright, Russell Maxwell, et al.
Annals of Palliative Medicine|August 22, 2020
Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear acceleratorAndrew R Barsky, Michele M Kim, Russell Maxwell, et al.
Clinical Lung Cancer|July 3, 2020
Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural MesotheliomaAndrew R Barsky, Christopher A Ahern, Sriram Venigalla, et al.
Advances in Radiation Oncology|November 24, 2022
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?Christopher M Wright, Alexandra D Dreyfuss, Jonathan A Baron, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2021
Palliative Radiotherapy for Diffuse Large B-cell LymphomaChristopher M Wright, Antony I Koroulakis, Jonathan A Baron, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Practical Radiation Oncology|March 19, 2022
Stricter Postoperative Oropharyngeal Cancer Radiation Therapy Normal Tissue Dose Constraints Are FeasibleWilliam Su, Christopher M Wright, Daniel Y Lee, et al.
Cancer Research|November 19, 2015
Fibulin-5 Blocks Microenvironmental ROS in Pancreatic CancerMiao Wang, Mary Topalovski, Jason E Toombs, et al.
Practical Radiation Oncology|July 6, 2024
Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell LymphomaJonathan A Baron, Christopher M Wright, Alexandra D Dreyfuss, et al.
Advances in Radiation Oncology|December 19, 2022
Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee CollaborationJonathan A Baron, Christopher M Wright, Russell Maxwell, et al.
Annals of Palliative Medicine|August 22, 2020
Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear acceleratorAndrew R Barsky, Michele M Kim, Russell Maxwell, et al.
Clinical Lung Cancer|July 3, 2020
Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural MesotheliomaAndrew R Barsky, Christopher A Ahern, Sriram Venigalla, et al.
Advances in Radiation Oncology|November 24, 2022
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?Christopher M Wright, Alexandra D Dreyfuss, Jonathan A Baron, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2021
Palliative Radiotherapy for Diffuse Large B-cell LymphomaChristopher M Wright, Antony I Koroulakis, Jonathan A Baron, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Pageof 3